uu.seUppsala universitets publikasjoner
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions
Icahn Sch Med Mt Sinai, New York, NY 10029 USA;Sema4, Stamford, CT USA.
Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England.
Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England.ORCID-id: 0000-0002-2169-6735
Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Clinical Pharmacology and Therapeutics, ISSN 0009-9236, E-ISSN 1532-6535, Vol. 106, nr 5, s. 1028-1036Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Carbamazepine (CBZ) causes life-threating T-cell-mediated hypersensitivity reactions, including serious cutaneous adverse reactions (SCARs) and drug-induced liver injury (CBZ-DILI). In order to evaluate shared or phenotype-specific genetic predisposing factors for CBZ hypersensitivity reactions, we performed a meta-analysis of two genomewide association studies (GWAS) on a total of 43 well-phenotyped Northern and Southern European CBZ-SCAR cases and 10,701 population controls and a GWAS on 12 CBZ-DILI cases and 8,438 ethnically matched population controls. HLA-A*31:01 was identified as the strongest genetic predisposing factor for both CBZ-SCAR (odds ratio (OR) = 8.0; 95% CI 4.10-15.80; P = 1.2 x 10(-9)) and CBZ-DILI (OR = 7.3; 95% CI 2.47-23.67; P = 0.0004) in European populations. The association with HLA-A*31:01 in patients with SCAR was mainly driven by hypersensitivity syndrome (OR = 12.9; P = 2.1 x 10(-9)) rather than by Stevens-Johnson syndrome/toxic epidermal necrolysis cases, which showed an association with HLA-B*57:01. We also identified a novel risk locus mapping to ALK only for CBZ-SCAR cases, which needs replication in additional cohorts and functional evaluation.

sted, utgiver, år, opplag, sider
WILEY , 2019. Vol. 106, nr 5, s. 1028-1036
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-396697DOI: 10.1002/cpt.1493ISI: 000488891600027PubMedID: 31066027OAI: oai:DiVA.org:uu-396697DiVA, id: diva2:1368910
Forskningsfinansiär
Swedish Heart Lung Foundation, 20140291Swedish Heart Lung Foundation, 20120557Swedish Research Council, 521-2014-3370Swedish Research Council, 521-2011-2440Swedish Society of Medicine, 2008-21619Tilgjengelig fra: 2019-11-08 Laget: 2019-11-08 Sist oppdatert: 2019-11-08bibliografisk kontrollert

Open Access i DiVA

fulltext(423 kB)23 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 423 kBChecksum SHA-512
009fa0035fa99dedc8f2cd5f3ed4b82cb04d7a23d41f2f598fa9cd0d6ffe36f81f4ff7d1a3794a4e50ac829cf514a1d1d12d52679d73e13cb1e8c4af313b6af7
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Wadelius, MiaHallberg, Pär

Søk i DiVA

Av forfatter/redaktør
McEvoy, LaurenceWadelius, MiaHallberg, Pär
Av organisasjonen
I samme tidsskrift
Clinical Pharmacology and Therapeutics

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 23 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 26 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf